According to our new research study on "Empty Capsules Market Forecast to 2031 - Global Analysis - by Product, Functionality, Application, End User, and Geography," the market is expected to grow from US$ 7,791.65 billion in 2024 to US$ 13,680.79 billion by 2031; it is estimated to record a CAGR of 8.5% from 2025-2031. Key factors driving the growth of the empty capsules market are the rising geriatric population, increased demand for empty capsules across industries, and growing preference for capsule-based medications.

The scope of the empty capsules market report includes the assessment of the market performance in North America, Europe, Asia Pacific, South and Central America, and the Middle East and Africa. Asia Pacific is anticipated to register the fastest CAGR in the empty capsules market from 2025 to 2031. The increase in health consciousness, the rise in the demand for dietary supplements, and the increase in the elderly population are the main drivers of the use of capsule-based drugs. The pharmaceutical and nutraceutical industries in the Asia Pacific region, especially in India, China, and Japan, are supporting the empty capsules market growth in the Asia Pacific because of their low-cost production and favorable government policies. Besides, the trend of switching over to vegetarian and gelatin-free capsules, which is caused by the preferences of consumers and the considerations of religion, has created a wider market, accelerating the growth of the Asia-Pacific empty capsules market in the near future. The production and delivery of drugs through technology in capsule manufacturing and the focus on personalized medicine have brought about the development of drug delivery systems, thus becoming a significant factor aiding the empty capsules market in the region. In addition, the markets growth has been facilitated by the factors of increased healthcare spending, enhanced healthcare infrastructure, and improved access to over-the-counter products. The contract manufacturing organizations (CMOs) in Asia Pacific are increasingly forming alliances with the global pharmaceutical companies, thus amplifying the production capacity and the prospect for exports. Lastly, regulatory changes that are aimed at making the drug approval processes across the region more uniform have also simplified the coming of new products into the market.

The nutraceutical boom in China is pushing the growth of empty capsules, as city-dwelling health-oriented customers are taking supplements, and the post-pandemic healthiness trend is ongoing. By-Health, the leading Chinese nutraceutical brand, is one of the companies that take advantage of this situation by employing vegetarian HPMC capsules for their green tea extract and collagen products, thus appealing to vegans and halal certifications for their products being sent to Southeast Asia. This trend is further amplified by the growing "silver economy" and the aging population of China, which is projected to exceed 300 million by the year 2025. Joint health supplements sold in pullulan-based capsules that are odorless and easy to swallow are thus gaining popularity among the elderly. Nutraceutical companies in Guangdong province, such as Amway (China) Co., Ltd., have set up localized production, using empty capsules for personalized mixes like elderberry immunity boosters, further fueling the growth of the empty capsules market.

Japans population is among the oldest in the world, with a very large percentage of its people being 65 years old or more. That demographic skewing means that there is always a steady market for drugs that fight off major diseases like heart disease and diabetes, Alzheimers, and other age-related ailments. The manufacturers and consumers preference for cleaner and easier swallowing types of medications also makes capsules more favorable over tablets in many cases. Empty capsules, known for being very easy to swallow and having precise dosing, perfectly meet direct this need and also facilitate the revelation of treatments for common diseases.

Furthermore, the empty capsules market is accelerating with the development of low-dose, capsule-encapsulated formulations for elderly patients with cardiovascular issues by Takeda Pharmaceutical, which illustrates how local companies are adapting to the changing demographics by lessening the pill burden and improving compliance. The age-related demand is pushing the domestic market and allowing Japanese companies to be ranked among the producers of special capsules for Europe and North America markets, bolstering the empty capsules market growth. Therefore, the factors mentioned above are promoting a favorable environment for the empty capsules market in the region.

Lonza Group, ACG Worldwide, Qualicaps Co. Ltd, Suheung Co. Ltd., CapsCanada Inc., HealthCaps India Private Limited, Natural Capsules Limited, Operio Group, UCB, and Roxlor LLC. are among the leading companies profiled in the empty capsules market report.

Based on product, the empty capsules market is bifurcated into gelatin capsules and non-gelatin capsules. By functionality, the market is segmented into immediate-release capsules, delayed-release capsules, and sustained-release capsules. On the basis of application, the empty capsules market is classified into antibiotic and antibacterial drugs, vitamin and dietary supplements, antacids and anti-flatulent preparations, and others. Per end user, the market is categorized into the pharmaceutical industry, the nutraceutical industry, the cosmetics industry, and research laboratories. Geographically, the empty capsules market is categorized into North America (US, Canada, and Mexico), Europe (France, Germany, UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East and Africa (Saudi Arabia, South Africa, the UAE, and the Rest of the Middle East and Africa), and South and Central America (Brazil, Argentina, and the Rest of South and Central America).

Contact Us
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com